2-Benzamidobenzoic Acid - CAS 579-93-1
Catalog: |
BB029893 |
Product Name: |
2-Benzamidobenzoic Acid |
CAS: |
579-93-1 |
Synonyms: |
2-benzamidobenzoic acid; 2-benzamidobenzoic acid |
IUPAC Name: | 2-benzamidobenzoic acid |
Description: | 2-Benzamidobenzoic Acid (CAS# 579-93-1) is a useful research chemical. |
Molecular Weight: | 241.24 |
Molecular Formula: | C14H11NO3 |
Canonical SMILES: | C1=CC=C(C=C1)C(=O)NC2=CC=CC=C2C(=O)O |
InChI: | InChI=1S/C14H11NO3/c16-13(10-6-2-1-3-7-10)15-12-9-5-4-8-11(12)14(17)18/h1-9H,(H,15,16)(H,17,18) |
InChI Key: | WXVLIIDDWFGYCV-UHFFFAOYSA-N |
Boiling Point: | 341.9 °C at 760 mmHg |
Melting Point: | 183.00 °C at 760.00 mm Hg |
Density: | 1.334 g/cm3 |
Solubility: | slightly |
Appearance: | White solid |
MDL: | MFCD00444173 |
LogP: | 2.71010 |
GHS Hazard Statement: | H302 (25.66%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P272, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P333+P313, P337+P313, P362, P363, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2021144475-A1 | Mr1 ligands and pharmaceutical compositions for immunomodulation | 20200116 |
WO-2021050832-A2 | Methods for treating cancer using serial administration of e3 ubiquitin ligase degraders | 20190912 |
CN-109232275-B | Preparation method of 4-nitrodiphenylamine and 4-nitrosodiphenylamine | 20181026 |
TW-202006138-A | Use of FUBP1 inhibitors for treating hepatitis B virus infection | 20180405 |
WO-2019193165-A1 | Use of fubp1 inhibitors for treating hepatitis b virus infection | 20180405 |
PMID | Publication Date | Title | Journal |
22897946 | 20120915 | N-Benzoyl anthranilic acid derivatives as selective inhibitors of aldo-keto reductase AKR1C3 | Bioorganic & medicinal chemistry letters |
21847495 | 20111021 | Anthranilic acid-based inhibitors of phosphodiesterase: design, synthesis, and bioactive evaluation | Organic & biomolecular chemistry |
21053346 | 20101203 | Inhibitors of the salicylate synthase (MbtI) from Mycobacterium tuberculosis discovered by high-throughput screening | ChemMedChem |
19540209 | 20091015 | DSM-RX78, a new phosphodiesterase inhibitor, suppresses superoxide anion production in activated human neutrophils and attenuates hemorrhagic shock-induced lung injury in rats | Biochemical pharmacology |
19703032 | 20090901 | Disubstituted 4(3H) quinazolones: a novel class of antitumor agents | Chemical biology & drug design |
Complexity: | 310 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 241.07389321 |
Formal Charge: | 0 |
Heavy Atom Count: | 18 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 241.07389321 |
Rotatable Bond Count: | 3 |
Topological Polar Surface Area: | 66.4 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 3.5 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS